Loading...
Effect of bevacizumab against cystic components of brain tumors
BACKGROUND: Bevacizumab improves symptoms via reducing the peritumoral edema and/or normalizing blood brain barrier, and occasionally via reducing the tumor size. However, the effect against active cystic components has not been documented yet. MATERIALS AND METHODS: Between 2008 and 2018, 139 patie...
Na minha lista:
| Udgivet i: | Cancer Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6825995/ https://ncbi.nlm.nih.gov/pubmed/31498567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2537 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|